| |
|
|
|
Fennec Pharmaceuticals Inc  
|
|
9.62 0.27 (0.03%) |
09-28 16:00 |
|
Open: |
9.36 |
Pre close: |
9.35 |
Target:
|
11.48 
|
|
High: |
9.83 |
Low: |
9.3454 |
Resistance:
|
9.83
11.48
|
|
Volume: |
42,354 |
Market Cap: |
250M |
Support:
|
8.28
7.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.30
|
MACD |
MACD(12,26):
|
0.50 |
|
MA(20): |
8.50 |
Signal(12,26,9): |
0.41 |
|
MA(100): |
7.21 |
Stochastic Oscillator |
%K(14,3):
|
89.50  |
|
MA(250): |
7.31 |
%D(3): |
91.21 |
|
Average Volume(K) |
3-Month: |
157213
|
52-Week |
High:
|
9.83 |
|
10-Days: |
4969 |
Low: |
5.80 |
|
RSI |
RSI(14):
|
75.30 |
Change(%): |
58.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.750 |
Return on Equity (ttm) |
-113.9 |
Shares Out. (M) |
26.00 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-62.1 |
Shares Float (M) |
19.84 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.94 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
56.33 |
|
Forward EPS |
-0.520 |
Gross Profit (p.s.) |
0.007 |
Shares Short (K) |
1370 |
|
Book Value (p.s.) |
0.960 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.83 |
|
Sales Per Share |
0.007 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.02 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.44 |
P/S |
1471.29 |
|
Operating Margin |
-11160.59 |
Levered Free Cash Flow
(M) |
-8.52 |
P/CF |
-16.20 |
|
|
|
|
|
|
